The Sahlgrenska University Hospital is a hospital network associated with the Sahlgrenska Academy at the University of Gothenburg in Gothenburg, Sweden. With 17,000 employees the hospital is the largest hospital in Sweden by a considerable margin, and the second largest hospital in Europe.

There are 2,000 beds in Department of Cardiology, Sahlgrenska University Hospital.

During the past decade, Department of Cardiology, Sahlgrenska University Hospital conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 1 clinical trials were completed, i.e. on average, 20% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Department of Cardiology, Sahlgrenska University Hospital" #1 sponsor was "Mats Heyman" with 2 trials, followed by "Vastra Gotaland Region" with 2 trials sponsored, "European Organisation for Research and Treatment of Cancer - EORTC" with 1 trials sponsored, "Hoffmann-La Roche" with 1 trials sponsored and "Lars Gullestad" with 1 trials sponsored. Other sponsors include -4 different institutions and companies that sponsored additional 6 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Department of Cardiology, Sahlgrenska University Hospital" #1 collaborator was "NordForsk" with 2 trials as a collaborator, "The Swedish Childhood Cancer Foundation" with 2 trials as a collaborator, "Aamu Pediatric Cancer Foundation" with 1 trials as a collaborator, "Aarhus University Hospital" with 1 trials as a collaborator and "Acreditar - Associação de Pais e Amigos das Crianças com Cancro" with 1 trials as a collaborator. Other collaborators include 24 different institutions and companies that were collaborators in the rest 34 trials.

According to Clinical.Site data, the most researched conditions in "Department of Cardiology, Sahlgrenska University Hospital" are "Breast Cancer" (2 trials), "Leukemia, Acute Lymphoblastic" (2 trials), "Angina, Unstable" (1 trials), "Cardiac Allograft Vasculopathy" (1 trials) and "Myocardial Stunning" (1 trials). Many other conditions were trialed in "Department of Cardiology, Sahlgrenska University Hospital" in a lesser frequency.

Most popular intervention types in "Department of Cardiology, Sahlgrenska University Hospital" are "Drug" (5 trials), "Other" (2 trials), "Procedure" (2 trials), "Biological" (1 trials) and "Diagnostic Test" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (2 trials), "6-tioguanine+Standard Maintenance Therapy" (1 trials), "Blinatumomab" (1 trials), "Bloodtest" (1 trials) and "Coronary angiography and revascularization if feasible" (1 trials). Other intervention names were less common.

The vast majority of trials in "Department of Cardiology, Sahlgrenska University Hospital" are 6 trials for "All" genders and 2 trials for "Female" genders.

Currently, there are NaN active trials in "Department of Cardiology, Sahlgrenska University Hospital". undefined are not yet recruiting, 3 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Department of Cardiology, Sahlgrenska University Hospital, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Department of Cardiology, Sahlgrenska University Hospital, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 5 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".